Aloys Alzheimer was a German neurohistologist who was such a workaholic that he would examine brain tissue throughout the night, catching a few hours of sleep the next day before beginning all over again.
Read More
We'd all like to escape dementia in our old age. Over the past decade, numerous large scale epidemiological studies have been published singing the praises of a variety of agents that might prevent or delay dementia.
Read More
Plaques and Tangles, Amyloid deposits and Apo-E: Who can keep them straight? Unless you are a researcher, all you really need to know is how to diagnose dementia, and how to dose the acetylcholinesterase inhibitor du jour.
Read More
If you were in TCR's editorial offices, surrounded by boxes of articles about acetylcholinesterase inhibitors (AChEI’s), you would quickly develop a sinking sensation. Not because the articles are so boring (though, in fact, they are); rather, because the pharmaceutical hype-sters are back on parade once again.
Read More
Dr. Aiken is the Editor in Chief of The Carlat Psychiatry Report; director of the Mood Treatment Center in North Carolina, where he maintains a private practice combining medication and therapy along with evidence-based complementary and alternative treatments; and Assistant Professor NYU Langone Department of Psychiatry. He has worked as a research assistant at the NIMH and a sub-investigator on clinical trials, and conducts research on a shoestring budget out of his private practice. Follow him on Twitter and find him on LinkedIn.
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.jpg?1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
